![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 8
2022
Zhu, Zhou; Turner, Nicholas C.; Loi, Sherene; Andre, Fabrice; Martin, Miguel; Dieras, Veronique; Gelmon, Karen A.; Harbeck, Nadia; Zhang, Cathy; Cao, Joan Q.; Yan, Zhengming; Lu, Dongrui R.; Wei, Ping; VanArsdale, Todd L.; Rejto, Paul A.; Huang, Xin; Rugo, Hope S.; Loibl, Sibylle; Cristofanilli, Massimo; Finn, Richard S. und Liu, Yuan
(2022):
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
In: Npj Precision Oncology, Bd. 6, Nr. 1, 56
Cristofanilli, Massimo; Rugo, Hope S.; Im, Seock-Ah; Slamon, Dennis J.; Harbeck, Nadia; Bondarenko, Igor; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Iwata, Hiroji; O'Leary, Ben; Andre, Fabrice; Loibl, Sibylle; Bananis, Eustratios; Liu, Yuan; Huang, Xin; Kim, Sindy; Frean, Maria Jose Lechuga und Turner, Nicholas C.
(2022):
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2(- )ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.
In: Clinical Cancer Research, Bd. 28, Nr. 16: S. 3433-3442
2021
Onesti, Concetta Elisa; Tagliamento, Marco; Curigliano, Giuseppe; Harbeck, Nadia; Bartsch, Rupert; Wildiers, Hans; Tjan-Heijnen, Vivianne; Martin, Miguel; Rottey, Sylvie; Generali, Daniele; Campone, Mario; Cristofanilli, Massimo; Pusztai, Lajos; Peeters, Marc; Berchem, Guy; Cortes, Javier; Ruhstaller, Thomas; Ciruelos, Eva; Rugo, Hope S. und Jerusalem, Guy
(2021):
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology.
In: Jco Global Oncology, Bd. 7: S. 162-172
2020
Onesti, Concetta Elisa; Rugo, Hope S.; Generali, Daniele; Peeters, Marc; Zaman, Khalil; Wildiers, Hans; Harbeck, Nadia; Martin, Miguel; Cristofanilli, Massimo; Cortes, Javier; Tjan-Heijnen, Vivianne; Hurvitz, Sara A.; Berchem, Guy; Tagliamento, Marco; Campone, Mario; Bartsch, Rupert; De Placido, Sabino; Puglisi, Fabio; Rottey, Sylvie; Müller, Volkmar; Ruhstaller, Thomas; Machiels, Jean-Pascal; Conte, PierFranco; Awada, Ahmad und Jerusalem, Guy
(2020):
Oncological care organisation during COVID-19 outbreak.
In: Esmo Open, Bd. 5, Nr. 4, e000853
2019
Turner, Nicholas C.; Liu, Yuan; Zhu, Zhou; Loi, Sherene; Colleoni, Marco; Loibl, Sibylle; DeMichele, Angela; Harbeck, Nadia; Andre, Fabrice; Bayar, Mohamed Amine; Michiels, Stefan; Zhang, Zhe; Giorgetti, Carla; Arnedos, Monica; Bartlett, Cynthia Huang und Cristofanilli, Massimo
(2019):
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
In: Journal of Clinical Oncology, Bd. 37, Nr. 14
2017
Loibl, Sibylle; Turner, Nicholas C.; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; Andre, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Theall, Kathy Puyana; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang und Dowsett, Mitchell
(2017):
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.
In: Oncologist, Bd. 22, Nr. 9: S. 1028-1038
2016
Cristofanilli, Massimo; Turner, Nicholas C.; Bondarenko, Igor; Ro, Jungsil; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Zhang, Ke; Theall, Kathy Puyana; Jiang, Yuqiu; Bartlett, Cynthia Huang; Koehler, Maria und Slamon, Dennis
(2016):
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial.
In: Lancet Oncology, Bd. 17, Nr. 4: S. 425-439
Verma, Sunil; Bartlett, Cynthia Huang; Schnell, Patrick; DeMichele, Angela M.; Loi, Sherene; Ro, Jungsil; Colleoni, Fmarco; Iwata, Hiroji; Harbeck, Nadia; Cristofanilli, Massimo; Zhang, Ke; Thiele, Alexandra; Turner, Nicholas C. und Rugo, Hope S.
(2016):
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).
In: Oncologist, Bd. 21, Nr. 10: S. 1165-1175